Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Illumina unveils latest entrants to accelerator in SF, U.K.

By stephen hansen, associate editor
February 9, 2021 2:21 AM UTC

Genomics player Illumina has added nine more start-ups to the stable of genomics newcos residing at its Illumina Accelerator.

On Monday, Illumina Inc. (NASDAQ:ILMN) announced the latest round of companies selected in the accelerator’s global cycle, with five joining its San Francisco location and four joining the recently launched Cambridge, U.K., center. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Illumina Inc.